Dr. Robert S. Kellar is the Founder and President of Development Engineering Sciences, LLC, a biomedical consulting firm. He has over 15 years of experience in the development and regulatory approval of medical devices, cell-based products, and tissue engineered technology.
Previously, Dr. Kellar was VP of Research and Development at Histogen, Inc. where he led multi-functional project teams for all aspects of product development. Prior to Histogen, Dr. Kellar was a product specialist for the first FDA-approved thoracic endograft at W.L. Gore and Associates where he served a lead role in product development, regulatory, clinical trials, marketing, sales, and business for the thoracic device and the product portfolio.
Dr. Kellar is an Associate Professor of Practice in the Center for Bioengineering Innovation at Northern Arizona University. Dr. Kellar has helped to co-found a number of companies including Flagship Biosciences, a digital pathology company, and Autogenesis Corporation, a wound healing company. He currently serves on the Scientific Advisory Board for MyoStim. He serves as an Advisory Board Member for Protein Genomics, a protein polymer medical device company, and the California Stock Exchange.